Aytu BioPharma (NASDAQ:AYTU) Releases Earnings Results

Aytu BioPharma (NASDAQ:AYTU) issued its earnings results on Wednesday. The company reported ($0.28) EPS for the quarter, Zacks reports. Aytu BioPharma had a negative net margin of 8.28% and a negative return on equity of 21.89%.

Aytu BioPharma Stock Performance

Shares of AYTU stock traded down $0.03 during trading hours on Wednesday, hitting $1.39. The company’s stock had a trading volume of 51,843 shares, compared to its average volume of 24,237. The stock has a market cap of $8.55 million, a PE ratio of -1.13 and a beta of -1.45. Aytu BioPharma has a 12-month low of $1.30 and a 12-month high of $3.45. The company has a 50 day moving average of $1.62 and a 200 day moving average of $2.01. The company has a current ratio of 0.99, a quick ratio of 0.80 and a debt-to-equity ratio of 0.35.

Aytu BioPharma Company Profile

Aytu Biopharma, Inc is a specialty pharmaceutical company, which engages in identifying, acquiring, and commercializing novel products. It operates through the Rx and Consumer Health segments. The RX segment consists of various prescription pharmaceutical products sold through third parties. The Consumer Health segment includes various consumer health products sold directly to consumers.